Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-09, Stock:LLY, The news for the past five days is as follows:
2018-06-29: NEWS1: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS2: Lilly's (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS3: Lilly&apos;s (LLY) Taltz Positive in Ankylosing Spondylitis Study.NEWS4: Eli Lilly’s Oncology Product Portfolio.NEWS5: Will a Trade War With China Wreak Havoc in US Healthcare?.NEWS6: Will a Trade War With China Wreak Havoc in US Healthcare?.NEWS7: Eli Lilly’s Neuroscience Product Portfolio.NEWS8: Eli Lily Highlights Study Results of Emgality for Migraines.NEWS9: LLY Announces Results for Emgality in Episodic Cluster Headaches.NEWS10: Eli Lilly’s Endocrine Product Portfolio.NEWS11: Lilly Announces Initiation of the Observational Survey of the Epidemiology, Treatment and Care of Migraine (OVERCOME) to Advance Understanding of Burden, Impact and Epidemiology of Migraine.
2018-07-02: NEWS1: Analysts’ Estimates and Recommendations for Eli Lilly in June.NEWS2: Eli Lilly’s Animal Health Business.NEWS3: Eli Lilly’s Cardiovascular Product Portfolio.NEWS4: Blog Exposure - Eli Lilly's Taltz(R) Meets Primary Endpoint in Phase-3 Study for Treatment of Ankylosing Spondylitis.
2018-07-03: NEWS1: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS2: Is Pfizer's Price Hike an Effect of Drug Policy on Sector?.NEWS3: Merck's Keytruda Gets Priority Review in Difficult Lung Cancer.NEWS4: Merck's Keytruda Gets Priority Review in Difficult Lung Cancer.NEWS5: Developments for Eli Lilly in June Include EASE Phase 3 Data.NEWS6: Remember When Was The Last Time A New Alzheimer's Drug Was Approved?.NEWS7: Remember When Was The Last Time A New Alzheimer's Drug Was Approved?.
2018-07-05: NEWS1: Some Recent Pharmaceutical Mergers and Acquisitions.NEWS2: Go Long Pfizer Stock — It’s an Easy Pill to Swallow.NEWS3: Go Long Pfizer Stock — It’s an Easy Pill to Swallow.NEWS4: Here’s Why Analysts See a Major Upside in Acadia Pharmaceuticals.NEWS5: Go Long Pfizer Stock — It’s an Easy Pill to Swallow.
2018-07-06: NEWS1: Alzheimer's Research Gets Glimmer of Hope, Not for First Time.NEWS2: Top Stocks Set to Disrupt the Diabetes Market.NEWS3: Biogen's Alzheimer Disease Candidate Succeeds in Phase II.NEWS4: Biogen's Alzheimer Disease Candidate Succeeds in Phase II.NEWS5: Biogen&apos;s Alzheimer Disease Candidate Succeeds in Phase II.NEWS6: Eli Lilly Stock’s June Performance.

Answer: Rise